Natco Pharma signs pact with Eli Lilly for Baricitinib

Withdraws application seeking Compulsory License against Lilly for the COVID-19 drug

Natco Pharma signs pact with Eli Lilly for Baricitinib
Linkup
Withdraws application seeking Compulsory License against Lilly for the COVID-19 drug